OUR MISSION:
TO PROTECT PUBLIC HEALTH, CONSUMER SAFETY, AND SAFEGUARD THE ENVIRONMENT BY PROMOTING INTEGRITY IN THE CANNABIS INDUSTRY

Executive Leadership

The Executive Leadership Team is comprised of business leaders from various fields that have been recruited to institute and implement the day-to-day operations at FOCUS. The Leadership Team is accountable to the Board of Directors and has responsibility for all operational aspects of the organization including overseeing standards development activities, developing operational policies and procedures, public education and public agency liaison activities, and preparing annual operating budgets. Members have been recruited because of their impressive dedication to the FOCUS mission and their ability to operationalize business entities.

Lezli Engelking – Founder & Executive Chair

Lezli Engelking possesses 18 years of professional experience across pharmaceutical, mental health, non-profit, cannabis and communication industries. More than 12 years with Eli Lilly laid the perfect foundation for her role as executive director of the first chain of vertically integrated cannabis operations in Arizona. Lezli’s proven success in the highly-regulated pharmaceutical industry and her first hand experience working in the unregulated cannabis industry place her in an ideal position to lead the company creating the first and only third-party validated, international, quality and safety-based, voluntary-consensus cannabis specific standards.

James Moser – Chief Operating Officer

James Moser brings three decades of experience in quality assurance, process management, manufacturing operations, project management, human resources, communication and organization development.

James learned Six Sigma principles at Motorola in the 1980s, contributing to the company in progressive roles in defense electronics, space systems, cellular and semiconductor divisions for 15 years.

He served on the core team to launch ON Semiconductor, a $2 billion operation divested from Motorola, directing human resources operations and leading change management for an Oracle enterprise systems implementation in 10 countries.

In 2001, James launched a professional services company that organizes and guides business start-up, restructuring, risk prevention and process management projects for diverse clients.

In 2015, James joined the Foundation of Cannabis Unified Standards to help develop and launch the first voluntary consensus standards for the industry. As COO, he leads the operationalization of company processes, systems and partnership integration.

James graduated from Arizona State University’s Walter Cronkite School of Journalism and is a lifetime member and past president of the Scottsdale League for the Arts charity.

Jeff Hicks – Director of Finance

Jeff Hicks brings 20 years of experience in finance management including corporate reporting, controlling and operational finance, and cash management. While consulting in the advertising and media industries, he developed forecasts, budgets and other key financial processes for a variety of organizations. During his tenure at Technicolor, Jeff contributed in progressive roles from controlling in the corporate office to finance director in operations. Jeff was instrumental in developing the financial model for the Foundation of Cannabis Unified Standards and joined the team in 2016. Jeff has a degree in finance from San Diego State University and an M.B.A. from Loyola Marymount University.

Chelsea Mulligan – Administrative Director

Chelsea Mulligan has experience in operations for Meraki Enterprises, for network solutions, patient management, customer service, employee management and marketing. Within the Cannabis industry, Chelsea has conceptualized efficient operations and patient flow procedures, increased patient visits in dispensaries, handled marketing campaigns in multiple markets through a variety of channels and set a standard for how patient care should be handled.

Dr. Gary Starr – Chief Medical Officer

Gary Starr is a practicing ER physician in Minnesota. Previously Gary has served in the Air Force in several medical capacities. Dr. Starr has been involved at the political/ legislative arena for Emergency Medicine on both the state, and national levels. One of Gary’s less traditional medical interests is the development of medical cannabis as a viable alternative to standard pharmaceutical options for various ailments. He and a partner started one of the first Minnesota registered medical cannabis manufacturing facilities. Dr. Starr continues to work in the business/science/political arena in an effort to move the medical cannabis industry forward.

Kris Morwood – Director of Development

Kris Morwood possesses more than 20 years of experience developing and implementing social responsibility programs. She specializes in community relations, regulatory compliance and non-profit launch and management. Kris develops, markets, promotes and manages campaigns that blend corporate responsibility, public relations and profitability. Kris’ skills portfolio includes board development, corporate event management and community relations. She brings outstanding communication and liaison experience to the FOCUS team.

Adam Mintz – Director

Adam Mintz has been an active participant in the cannabis industry since 2007. He cofounded and was CEO of two California infused product companies, CannaCatering and Tetralabs, and he assisted in the development of the California Association for the Production Safe Cannabis Edibles (CAPSCE), which promoted best practices. Adam’s interest in quality control and patient safety led to his two-year role as President of Steep Hill Labs, the nation’s first cannabis analytical laboratory. During his role as President, Adam served patients and stakeholders, and he also assisted regulators from Nevada Department of Public and Behavioral Health, Illinois Department of Agriculture and others on understanding the importance of sensible testing regulations.Adam remains committed to improving the cannabis industry through sustainability and standards while continuing to support drug reform laws and ending federal cannabis prohibition.